Effects of CD40 signal on induction of DC2 differentiation from CD34~+ hemopoietic cell of human cord blood in vitro

YIN Qing,SHAO Qi-xiang,WANG Jin-hu,WANG Sheng-jun,WEN Ping,PAN Xiang-tao,XU Hua-xi,ZHANG Xue-guang

DOI: https://doi.org/10.3969/j.issn.1000-8861.2006.04.026

2006-01-01

Abstract:Objective To develop a method of inducing DC2 from human cord blood CD34~+ hemopoietic cells and evaluate the effect of CD40 signal on differentiation and induction of DC2. Methods CD34~+ hemopoietic cells were isolated from cord blood of healthy volunteers with CD34-FITC and anti-FITC labeled magnetic microbeads, then cultured with rhIL-3 (10 ng/mL), rhFlt-3L (100 ng/mL), and rhGM-CSF (100 ng/mL). The surface molecules of DC2 were identified by FCM and the role of anti-CD40 mAb in differentiation and maturation of DC2 was analyzed by cytokines assay. Results CD34~+ hemopoietic cells of human cord blood were cultured with rhIL-3, rhFlt-3L, and rhGM-CSF for 12 days, and then rhIL-3+anti-human CD40mAb (groupⅠ) or rhIL-3+ TNF-α (groupⅡ) were added respectively to induce their differentiation and maturation. The expression rates of surface molecules HLA-DR, CD83, CD86, and CD80 on Lineage~-CD123~+ DC2 induced by groupⅠwere 88.78%, 37.38%, 32.83%, and 99.08%, respectively; otherwise the same surface molecules on Lineage~-CD123~+ DC2 induced by groupⅡ were 78.87%, 32.29%, 29.57%, and 98.86%, respectively. Conclusion DC2 can be induced from cord blood CD34~+ hemopoietic cells with cytokines cocktail in vitro. The agonist anti-human CD40mAb can enhance the differentiation and maturation of DC2.